4
Changes in Ownership
Aligos Therapeutics, Inc. Filed Acc 0001567619-22-002892
Options or other derivatives
- Chief Executive Officer acquired 404,250 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X03/doc1.xml…